Background/aims:
"Number needed to" metrics may hold more intuitive appeal for clinicians than standard diagnostic accuracy measures. The aim of this study was to calculate "number needed to diagnose" (NND), "number needed to predict" (NNP), and "number needed to misdiagnose" (NNM) for neurological signs of possible value in assessing cognitive status.
Methods:
Data sets from pragmatic diagnostic accuracy studies examining easily observed and dichotomised neurological signs ("attended alone" sign, "attended with" sign, head turning sign, applause sign, ) were analysed to calculate the NND, NNP, and NNM.
Results:
All measures of discrimination showed broad ranges. The range of NND and NNP suggested that these signs were, with a single exception, of value for correctly diagnosing or predicting cognitive status (presence or absence of cognitive impairment) when between 2 and 4 patients were examined. However, NNM showed similar values (range 1-5 patients) suggesting risk of misdiagnosis.
Conclusion:
NND, NNP, and NNM may be useful, intuitive, metrics in assessing the utility of diagnostic tests in day-to-day clinical practice. A ratio of NNM to either NND or NNP, termed the likelihood to diagnose or misdiagnose, may clarify the utility or inutility of diagnostic tests.
Citing Articles
Diagnostic tests performance indices: an overview.
Habibzadeh F
Biochem Med (Zagreb). 2025; 35(1):010101.
PMID: 39974192
PMC: 11838712.
DOI: 10.11613/BM.2025.010101.
Prediction of Osteoporotic Hip Fracture Outcome: Comparative Accuracy of 27 Immune-Inflammatory-Metabolic Markers and Related Conceptual Issues.
Fisher A, Fisher L, Srikusalanukul W
J Clin Med. 2024; 13(13).
PMID: 38999533
PMC: 11242639.
DOI: 10.3390/jcm13133969.
Evaluating the performance of a risk assessment score tool to predict HIV acquisition among pregnant and postpartum women in Kenya.
Chhun N, Rothschild C, Penumetsa M, Matemo D, Kithao P, Richardson B
PLoS One. 2024; 19(7):e0306992.
PMID: 38985777
PMC: 11236202.
DOI: 10.1371/journal.pone.0306992.
The Price of Explainability in Machine Learning Models for 100-Day Readmission Prediction in Heart Failure: Retrospective, Comparative, Machine Learning Study.
Soliman A, Agvall B, Etminani K, Hamed O, Lingman M
J Med Internet Res. 2023; 25:e46934.
PMID: 37889530
PMC: 10638630.
DOI: 10.2196/46934.
Patterns of risk-Using machine learning and structural neuroimaging to identify pedophilic offenders.
Popovic D, Wertz M, Geisler C, Kaufmann J, Lahteenvuo M, Lieslehto J
Front Psychiatry. 2023; 14:1001085.
PMID: 37151966
PMC: 10157073.
DOI: 10.3389/fpsyt.2023.1001085.
Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator.
Stenzinger A, Cuffel B, Paracha N, Vail E, Garcia-Foncillas J, Goodman C
Oncologist. 2023; 28(5):e242-e253.
PMID: 36961477
PMC: 10166172.
DOI: 10.1093/oncolo/oyad005.
Derivation and Internal Validation of a Risk Score for Predicting Chlamydia trachomatis Infection in Kenyan Women Planning Conception.
Pulei A, Lokken E, Kinuthia J, Richardson B, Mandaliya K, Jaoko W
Sex Transm Dis. 2023; 50(9):625-633.
PMID: 36877639
PMC: 11329225.
DOI: 10.1097/OLQ.0000000000001795.
Assessment of the Efficiency of Non-Invasive Diagnostic Imaging Modalities for Detecting Myocardial Ischemia in Patients Suspected of Having Stable Angina.
Iwata K, Ogasawara K
Healthcare (Basel). 2023; 11(1).
PMID: 36611483
PMC: 9818638.
DOI: 10.3390/healthcare11010023.
Comparison of Prognostic Value of 10 Biochemical Indices at Admission for Prediction Postoperative Myocardial Injury and Hospital Mortality in Patients with Osteoporotic Hip Fracture.
Fisher A, Srikusalanukul W, Fisher L, Smith P
J Clin Med. 2022; 11(22).
PMID: 36431261
PMC: 9696473.
DOI: 10.3390/jcm11226784.
Cognitive screening instruments for dementia: comparing metrics of test limitation.
Larner A
Dement Neuropsychol. 2022; 15(4):458-463.
PMID: 35509792
PMC: 9018083.
DOI: 10.1590/1980-57642021dn15-040005.
An 8-gene machine learning model improves clinical prediction of severe dengue progression.
Liu Y, Saul S, Rao A, Robinson M, Agudelo Rojas O, Sanz A
Genome Med. 2022; 14(1):33.
PMID: 35346346
PMC: 8959795.
DOI: 10.1186/s13073-022-01034-w.
Communicating Risk: Developing an "Efficiency Index" for Dementia Screening Tests.
Larner A
Brain Sci. 2021; 11(11).
PMID: 34827472
PMC: 8615719.
DOI: 10.3390/brainsci11111473.
MACE for Diagnosis of Dementia and MCI: Examining Cut-Offs and Predictive Values.
Larner A
Diagnostics (Basel). 2019; 9(2).
PMID: 31064141
PMC: 6627673.
DOI: 10.3390/diagnostics9020051.